Research Articles Library
Literature Analysis Tools
Advanced Search
Filter by PMID, year, source, DOI and other criteria
Literature Analysis
Analyze research trends and hotspots
Batch Export
Export search results to Excel/PDF
Machine Learning-Based Prediction of Pediatric Ulcerative Colitis Treatment Response Using Diagnostic Histopathology
Publication Year: 2024 Source: Gastroenterology PMID: 38309631
No Abstract
Sophocarpine alleviates intestinal fibrosis via inhibition of inflammation and fibroblast into myofibroblast transition by targeting the Sirt1/p65 signaling axis
Publication Year: 2024 Source: Eur J Pharmacol PMID: 38309678
No Abstract
Monitoring-Based Model for Personalizing Fecal Incontinence in Patients With Crohn's Disease: A Multicenter Inception Cohort Study
Publication Year: 2024 Source: Inflamm Bowel Dis PMID: 38309715
No Abstract
Diagnostic Performance of a Fecal Calprotectin Assay as a Biomarker for Mayo Endoscopic Subscore in Ulcerative Colitis: Result From a Tertiary Referral Center
Publication Year: 2024 Source: Inflamm Bowel Dis PMID: 38309716
No Abstract
Tofacitinib in ulcerative colitis - In the era of precision medicine'
Publication Year: 2024 Source: Dig Liver Dis PMID: 38310053
No Abstract
Etrolizumab-s fails to control E-Cadherin-dependent co-stimulation of highly activated cytotoxic T cells
Publication Year: 2024 Source: Nat Commun PMID: 38310086
No Abstract
Longitudinal assessment of sweat-based TNF-alpha in inflammatory bowel disease using a wearable device
Publication Year: 2024 Source: Sci Rep PMID: 38310197 DOI: 10.1038/s41598-024-53522-1
Wearable devices can non-invasively monitor patients with chronic diseases. Sweat is an easily accessible biofluid for continuous sampling of analytes, including inflammatory markers and cytokines. We evaluated a sweat sensing wearable device in subjects with and without inflammatory bowel disease (IBD), a chronic inflammatory condition of the gastrointestinal tract. Participants …
Recent Insight into Herbal Bioactives-based Novel Approaches for Chronic Intestinal Inflammatory Disorders Therapy
Publication Year: 2024 Source: Curr Pharm Biotechnol PMID: 38310453 DOI: 10.2174/0113892010282432231222060355
Inflammatory bowel disease (IBD) is a life-threatening complex disease. It causes chronic intestinal inflammation in GIT. IBD significantly affects people's lifestyles and carries a high risk of colon cancer. IBD involves the rectum, ileum, and colon, with clinical manifestations of bloody stools, weight loss, diarrhea, and abdominal pain. The prevalence …
Structured Reporting of Computed Tomography Enterography in Crohn's Disease
Publication Year: 2024 Source: Curr Med Imaging PMID: 38310552
No Abstract
Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis Through 5 Years in Crohn's Disease and 4 Years in Ulcerative Colitis
Publication Year: 2024 Source: J Crohns Colitis PMID: 38310565 DOI: 10.1093/ecco-jcc/jjae013
BACKGROUND AND AIMS: Previously published long-term safety data reported a favourable ustekinumab safety profile for the treatment of inflammatory bowel disease [IBD]. We present the final cumulative safety data from pooled ustekinumab IBD phase 2/3 clinical studies through 5 years in Crohn's disease [CD] and 4 years in ulcerative colitis …
Need more literature?
The current database contains 98453 research articles. If you need to search for more literature or perform AI analysis, please use our knowledge acquisition module or explore external literature resources.
External Resources: Access comprehensive literature databases worldwide